Speakers:
- Alisa Serio, Executive Director of Microbiology and Nonclinical Development, Paratek Pharmaceuticals (USA)
- Victoria Savage, Chief Scientific Officer, INFEX Therapeutics Ltd (UK)
Moderator: Daniel Ritz, Senior Director – Senior Group Leader Biology Technologies / Lead Discovery, Idorsia Pharmaceuticals Ltd. (Switzerland)
Schedule:
0:00 Webinar opening words
03:50 Presentation 1: Progression criteria and go/no go decisions in antibacterial drug discovery – a perspective from Paratek Pharma (Alisa Serio)
28:12 Presentation 2: Progressing an antibacterial drug discovery program – a perspective from INFEX Therapeutics (Victoria Savage)
50:14 Questions & Answers
GARDP: [ Ссылка ]
REVIVE: [ Ссылка ]
#webinar #GARDP #REVIVE #amr #antibiotics #researchanddevelopment #discovery
